May 19, 2023
29:20
For every 20 shares held, investors received 29. The price per share adjusted from $28.35 to $19.55.
The split itself did not change the total investment value.
Zhejiang Anglikang Pharmaceutical Co. Ltd. Class A (SZSE:002940) operates in the Pharmaceuticals: major industry.
Zhejiang Anglikang Pharmaceutical Co. Ltd. Class A company overviewZhejiang Anglikang Pharmaceutical Co. Ltd. Class A's most recent stock split was on May 19, 2023. It was a 29-for-20 forward split, so shareholders received 29 shares for every 20 they held.
Zhejiang Anglikang Pharmaceutical Co. Ltd. Class A (SZSE:002940) has split its stock 2 times: a 29-for-20 split on November 15, 2022 and a 29-for-20 split on May 19, 2023.
Zhejiang Anglikang Pharmaceutical Co. Ltd. Class A has split its stock 2 times. This history records 2 forward splits between November 15, 2022 and May 19, 2023.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Zhejiang Anglikang Pharmaceutical Co. Ltd. Class A's 29-for-20 split on May 19, 2023, every 20 shares became 29 shares.
Zhejiang Anglikang Pharmaceutical Co. Ltd. Class A has not announced a new split in our records. Its most recent split was on May 19, 2023, 3 years ago. Companies announce splits in advance, and any new SZSE:002940 split will appear on this page.
Already premium?